When comparing the expression levels of C1orf50 by IDC subtype, it was found that Luminal A breast cancer showed significantly higher expression levels of C1orf50 than non-Luminal A breast cancer (Fig. 1A). This evidence concerns the gene C1orf50 and breast carcinoma.